Fundraising Fox

Wellvana

Nashville, US · 6 known investors

Wellvana is a value-based care enablement company that operates ACOs across MSSP tracks and Medicare Advantage contracts and provides onboarding, clinical support, and the Clarity analytics platform to turn clinical, financial, and social data into care insights. It serves hospitals, health systems, and independent physician groups across 40 U.S. states.

Data & InfrastructureDigital HealthHealthtech

Founders & leadership

SL
SCOTT LENZExecutive
IK
IAN KYLE WAILESExecutive
AH
Adam HollandNamed on SEC filing

Board

CMCharlie Martin
Charlie MartinBoard directorFounder and Chairman at Martin Ventures
DCDevin Carty
Devin CartyBoard directorCEO at Martin Ventures
KW
KAREY WITTYBoard director
JP
Jon PhillipsBoard director
RM
Rock MorphisBoard director
RH
RAO HARIS NASEEMBoard director
PRPhillip Roe
Phillip RoeinBoard directorSenior Advisor at Martin Ventures

Investors · 6

Corewell Health VenturesGrand Rapids
Martin VenturesNashville · $2M – $4M
Optum VenturesBoston
Whistler Capital PartnersNashville
First Trust Capital PartnersreportedWheaton · $5M
Welsh, Carson, Anderson & Stowereported

Reported raises · per SEC filings

Form D private placements

$161.2M disclosed across 5 rounds · 2022–2024

▶$20MraisedFeb 2025 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • KAREY WITTYDirector
  • JON PHILLIPSDirector
  • ROCK MORPHISDirector
  • RAO HARIS NASEEMDirector
  • SCOTT LENZExecutive Officer
  • PHILLIP ROEDirector
  • CHARLIE MARTINDirector
  • IAN KYLE WAILESExecutive Officer, Director
  • DEVIN CARTYDirector
Offering amount
$20M
Amount sold
$20M
First sale
Nov 2024
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.5MraisedJul 2023 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jon PhillipsDirector
  • Rock MorphisDirector
  • Devin CartyDirector
  • Kyle WailesExecutive Officer, Director
  • Karey WittyDirector
  • Charlie MartinDirector
  • Adam HollandExecutive Officer
  • Rao NaseemExecutive Officer, Director
  • Scott LenzExecutive Officer
  • Phillip RoeDirector
Offering amount
$15.5M
Amount sold
$15.5M
Sales commissions
$675K
Placement agents
SVB SECURITIES LLC
First sale
Jul 2023
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$42MraisedMar 2023 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Rock MorphisDirector
  • Kyle WailesExecutive Officer, Director
  • Phillip RoeDirector
  • Devin CartyDirector
  • Adam HollandExecutive Officer
  • Scott LenzExecutive Officer
  • Jon PhillipsDirector
  • Charlie MartinDirector
  • Rao Haris NaseemExecutive Officer, Director
  • Karey WittyDirector
Offering amount
$42M
Amount sold
$42M
Sales commissions
$2.3M
Placement agents
SVB SECURITIES LLC
First sale
Mar 2023
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$64.5MraisedMar 2023 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jon PhillipsDirector
  • Phillip RoeDirector
  • Devin CartyDirector
  • Charlie MartinDirector
  • Adam HollandExecutive Officer
  • Rock MorphisDirector
  • Kyle WailesExecutive Officer, Director
  • Rao Haris NaseemExecutive Officer, Director
  • Scott LenzExecutive Officer
Offering amount
$64.5M
Amount sold
$64.5M
Sales commissions
$1.5M
Proceeds to insiders
$375K
Placement agents
SVB SECURITIES LLC
First sale
Feb 2023
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.1MraisedApr 2022 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jon PhillipsDirector
  • Michael PlatekExecutive Officer
  • Charlie MartinDirector
  • Devin CartyDirector
  • Scott LenzExecutive Officer
  • Darren MajorsExecutive Officer
  • Zachary TopperExecutive Officer
  • Kyle WailesExecutive Officer, Director
  • Readus SmithExecutive Officer
  • Sean HensonExecutive Officer
  • Cassie SmithExecutive Officer
  • Mark Montoney, MDExecutive Officer
  • Phillip RoeDirector
Offering amount
$19.1M
Amount sold
$19.1M
First sale
Apr 2022
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

CVS sells Medicare Shared Savings business to Wellvana | Healthcare Divehealthcaredive.com · Mar 2025Wellvana Health raises $84M to expand value-based care platform | MobiHealthNewsmobihealthnews.com · Mar 2023Locally based physician network raises $84M | Health Care | nashvillepost.comnashvillepost.com · Mar 2023Value-based care enabler Wellvana clinches $84M to expand in existing, new marketsfiercehealthcare.com · Mar 2023Wellvana Health announces $84 million capital raise to drive innovation in value-based care enablementprnewswire.com · Mar 2023Wellvana Health raises more than $64.5 million - Nashville Business Journalbizjournals.com · Mar 2023

Frequently asked questions

What does Wellvana do?
Wellvana is a value-based care enablement company that operates ACOs across MSSP tracks and Medicare Advantage contracts and provides onboarding, clinical support, and the Clarity analytics platform to turn clinical, financial, and social data into care insights. It serves hospitals, health systems, and independent physician groups across 40 U.S. states.
Who are Wellvana's investors?
Wellvana's investors include Corewell Health Ventures, Martin Ventures, Optum Ventures, Whistler Capital Partners, First Trust Capital Partners, Welsh, Carson, Anderson & Stowe.
How much funding has Wellvana raised?
Wellvana has disclosed $161.2M raised across 5 rounds.
Where is Wellvana headquartered?
Wellvana is headquartered in Nashville, US.